These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 28250927)
21. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE; Monasterolo G; Coco G; Operti D Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987 [TBL] [Abstract][Full Text] [Related]
22. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Maspero JF; Walters RD; Wu W; Philpot EE; Naclerio RM; Fokkens WJ Allergy Asthma Proc; 2010; 31(6):483-92. PubMed ID: 21708060 [TBL] [Abstract][Full Text] [Related]
23. Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients. Dreborg S; Lee TH; Kay AB; Durham SR Int Arch Allergy Immunol; 2012; 158(1):63-70. PubMed ID: 22212720 [TBL] [Abstract][Full Text] [Related]
24. Impact of IgE-mediated hypersensitivity on nasal mucociliary clearance. Kirtsreesakul V; Somjareonwattana P; Ruttanaphol S Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):801-6. PubMed ID: 20713757 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of commercial timothy grass pollen extracts. Focke M; Marth K; Flicker S; Valenta R Clin Exp Allergy; 2008 Aug; 38(8):1400-8. PubMed ID: 18564332 [TBL] [Abstract][Full Text] [Related]
26. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU). Ellis AK; Soliman M; Steacy LM; Adams DE; Hobsbawn B; Walker TJ Allergy Asthma Clin Immunol; 2016; 12():53. PubMed ID: 27777594 [TBL] [Abstract][Full Text] [Related]
27. Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract. Martínez-Cócera C; Sastre J; Cimarra M; Quirce S; Fernández-Rivas M; Enríquez-Matas A; Rodríguez-Alvarez M; Martín S J Investig Allergol Clin Immunol; 2010; 20(1):13-9. PubMed ID: 20232769 [TBL] [Abstract][Full Text] [Related]
28. The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization. Calus L; Devuyst L; Van Zele T; De Ruyck N; Derycke L; Bachert C; Gevaert P Clin Exp Allergy; 2016 Apr; 46(4):555-63. PubMed ID: 26661927 [TBL] [Abstract][Full Text] [Related]
29. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE. Cox LS; Casale TB; Nayak AS; Bernstein DI; Creticos PS; Ambroisine L; Melac M; Zeldin RK J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534 [TBL] [Abstract][Full Text] [Related]
32. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons]. Paranos S; Petrović S; Vojović I Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408 [TBL] [Abstract][Full Text] [Related]
33. Component-resolved diagnosis for phleum allergy: the role of recombinants. De Amici M; Alesina R; Moratti R; Ciprandi G J Asthma; 2010 Sep; 47(7):750-3. PubMed ID: 20726834 [TBL] [Abstract][Full Text] [Related]
34. [Rhinitis in adults]. Kalogjera L Acta Med Croatica; 2011; 65(2):181-7. PubMed ID: 22359885 [TBL] [Abstract][Full Text] [Related]
38. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy. Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
40. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion. Barchuk WT; Salapatek AM; Ge T; D'Angelo P; Liu X J Allergy Clin Immunol; 2013 Oct; 132(4):838-46.e1-6. PubMed ID: 23791513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]